Results 11 to 20 of about 311,597 (42)

Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction [PDF]

, 2016
Neurotoxicity is a common side effect of chemotherapy treatment, with unclear molecular mechanisms. Clinical studies suggest that the most frequent neurotoxic adverse events affect memory and learning, attention, concentration, processing speeds and ...
Abraham, Ahdieh, Ahles, Ahles, Al-Dasooqi, Al-Dasooqi, Al-Dasooqi, Alkam, Argaw, Argaw, Asahi, Ashburner, Bauer, Bercik, Blanco, Bona, Bourke, Boussios, Bowen, Bower, Brown, Brown, Brown, Caliceti, Capuron, Chen, Cheng, Chidlow, Chodobski, Collado-Hidalgo, Corps, Cummins, D'Alessio, Dantzer, Deprez, Deprez, Dietrich, Dietrich, Dietrich, Ferguson, Frank, Gahtan, Galvez, Gangloff, Gatti, Genschaft, Ginos, Goehler, Guo, Han, Henriksen, Higashida, Hjermstad, Holden, Holmes, Horky, in't Veld, Inagaki, Janelsins, Jenkins, Jenkins, Jiao, Jickling, Komaki, Krabbe, Krabbe, Laye, Lepage, Li, Lischper, Liu, Logan, Logan, McDonald, McDonald, Meyers, Minter, Mustian, Natah, Nokia, Nyuyki, Pan, Pan, Papadakis, Patel, Proescholdt, Quan, Riazi, Rochfort, Rodriguez, Roque, Schreibelt, Seigers, Seigers, Sharma, Sharma, Sharma, Simo, Sodeck, Sonis, Sparkman, Stringer, Stringer, Tannock, Trask, Vardy, Vermeer, Villena, Vink, Vries, Wang, Wardill, Wardill, Wardill, Wardill, Wardill, Wardill, Wardill, Wong, Wu, Zonis   +120 more
core   +1 more source

Ischemia–reperfusion impairs blood–brain barrier function and alters tight junction protein expression in the ovine fetus [PDF]

, 2012
The blood–brain barrier is a restrictive interface between the brain parenchyma and the intravascular compartment. Tight junctions contribute to the integrity of the blood–brain barrier.
Banks, W. A., Besio, W. G., Chen, X., Cummings, E. E., Gaitanis, J., Juan, I., Makeyev, O., Sadowska, G. B., Stonestreet, B. S., Threlkeld, S. W.   +9 more
core   +2 more sources

Age-related changes in blood-brain barrier integrity in C57BL/6J mice [PDF]

, 2013
The blood-brain barrier (BBB) is formed by the endothelial cells of the brain microvasculature, which control the molecular traffic between the blood and brain to maintain the neural ...
Romero, I. A., Saffrey, M. J., Wang, C.
core  

Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier [PDF]

, 2015
To clarify the significance of immunoglobulin G autoantibody specific for the astrocyte water channel aquaporin-4 in cerebrospinal fluid, aquaporin-4-immunoglobulin G from a neuromyelitis optica patient was administered intrathecally to naïve mice, and ...
Asgari, Nasrin, Berg, Carsten Tue, Khorooshi, Reza, Mørch, Marlene Thorsen, Owens, Trevor   +4 more
core   +1 more source

Pathogenetical significance of porencephalic lesions associated with intracerebral inoculation of sheep with the bovine spongiform encephalopathy (BSE) agent [PDF]

, 2009
Decreased rates of transmission of transmissible spongiform encephalopathies (TSEs) to sheep have been attributed to some polymorphisms of the prion protein (PrP) and to a ‘species barrier’ on interspecies experiments.
Card, Cotran, Detwiler, Foster, Foster, Fraser, Goldmann, González, González, Hamir, Hamir, Hamir, Houston, Houston, Houston, Hunter, Jeffrey, McLennan, Nakaoke, Outram, Weller, Zakharov   +21 more
core   +1 more source

N-alkylamides : from plant to brain [PDF]

, 2014
Background: Plant N-alkylamides (NAAs) are bio-active compounds with a broad functional spectrum. In order to reach their pharmacodynamic targets, they have to overcome several barriers of the body in the absorption phase.
De Spiegeleer, Bart, Joshi, Tanmayee, Taevernier, Lien, Tatke, Pratima, Verbeke, Frederick, Veryser, Lieselotte, Wynendaele, Evelien   +6 more
core  

The restorative role of annexin A1 at the blood–brain barrier [PDF]

, 2016
Annexin A1 is a potent anti-inflammatory molecule that has been extensively studied in the peripheral immune system, but has not as yet been exploited as a therapeutic target/agent. In the last decade, we have undertaken the study of this molecule in the
A Aggarwal, A Algotsson, A Armulik, A Cignarella, A Kosicka, A Mahringer, A Moheet, A Montagne, A Parimisetty, A Razmara, A Rosell, A Varatharaj, AB Mitchell, ACC Fonseca da, AJ Farrall, AJ Kiliaan, AK Deo, AK Harris, AM Stranahan, AMS Hartz, AMS Hartz, AP Viggars, AR Nelson, B Engelhardt, B Engelhardt, B Harten van, B Obermeier, B Shao, B Stieger, B-O Nilsson, BJ Andreone, BL Hart, BO Popescu, BT Hawkins, BV Zlokovic, BW Chow, BW McColl, C Derada Troletti, C Joseph, C Knott, C Moran, C Wang, CA Raji, CE Tagoe, CH Hillman, CJ Ek, CN Hall, CV Carman, CW D’Acunto, D Virgintino, D Virgintino, DA Eberhard, DR Thal, DW Kim, DY Yoo, E Brailoiu, E Cristante, E Duinkerken Van, E Maggioli, E Pietronigro, E Solito, E Zenaro, F Boraldi, F Bruschi, F Shimizu, FN Doubal, FNE Gavins, FR Walter, G Cheng, G Cirino, G Fredman, G Han, G Leoni, GG Ortiz, GJ Zoppo del, GL Bowman, H Kang, H Kim, H Qosa, H Sun, H Wang, HJ Haar van de, HK Smith, HS Kang, IA Simpson, J Deng, J Guo, J Satoh, J Tu, J-H Liu, JA Shin, JA Shin, JD Sengillo, JH Heo, JI Alvarez, JM Wardlaw, JS Saczynski, K Monastyrskaya, KM Thrailkill, L Bloemendaal van, L Nathan, L Parente, L Raz, L Sanchez-Covarrubias, L Zhou, L-C Chen, LA Profenno, LB Buckman, LD Ghitescu, M Asgari, M Brkic, M Burek, M Burek, M Elahy, M Fuente de la, M Hellström, M Perretti, M Perretti, M Schwaninger, MA Lopez-Ramirez, MA Lopez-Ramirez, MS Thomsen, N Gorlé, N Muradashvili, N Pannacciulli, N Sumi, NJ Abbott, NJ Abbott, NJ Abbott, NR Saunders, NT Pietrani, P Hu, PJ Magistretti, Q-H Liu, R Deane, R Hallmann, R Sankowski, RC Janzer, RD Bell, RF Haseloff, RH McCusker, RO Roberts, RT Kovacic, S Bena, S Burgmans, S Liebner, S Maysami, S McArthur, S Nadkarni, S Nourshargh, S Ouyang, S Probst-Cousin, S Rius-Pérez, S Suzuki, S Taheri, S Tietz, S Wang, SA Vital, SE Headland, SE Kanoski, SE Moss, SN Cooray, T Nishioku, TL Davidson, TO Price, TS Salameh, WS Hoogenboom, Y Luo, Y Yao, Y-F Tu, YH Jing, YH Lee, Z Tucsek, ZZ Luo   +173 more
core   +4 more sources

Ammonia : this is not the end but rather the end of the beginning [PDF]

, 2018
Hepatic encephalopathy (HE) represents a wide spectrum of neurological or neuropsychological symptoms caused by liver disease and/or portosystemic shunts.
Dam, Gitte, Rose, Christopher, Weiss, Nicolas   +2 more
core   +1 more source

Chronic Kidney Disease Increases Cerebral Microbleeds in Mouse and Man. [PDF]

, 2020
Brain microbleeds are increased in chronic kidney disease (CKD) and their presence increases risk of cognitive decline and stroke. We examined the interaction between CKD and brain microhemorrhages (the neuropathological substrate of microbleeds) in ...
Bangash, Maria, Cribbs, David H, Fisher, Mark, Floriolli, David, Lau, Wei Ling, Lertpanit, Long, Naqvi, Sameen, Nunes, Ane CF, Paganini-Hill, Annlia, Savoj, Javad, Shah, Krunal, Vasilevko, Vitaly, Vaziri, Nosratola D, Yao, Zhihui   +13 more
core  

Metabolic syndrome and the immunological affair with the blood-brain barrier [PDF]

, 2015
Copyright © 2015 Mauro, De Rosa, Marelli-Berg and Solito. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) .
De Rosa, V, Marelli-Berg, F, Mauro, C, Solito, E   +3 more
core   +1 more source